Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of YMN-A02 in Advanced pMMR Colorectal Cancer With Liver Metastases
NCT07610707Phase 1Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial of YMN-A02 in colorectal cancer (CRC) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Dose-Limiting Toxicity. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
YMN-A02
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07610707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07610707.